Volume 14 Issue 6 - 2022
A Necessary Reflection on the Comprehensive Care of Patients with Epilepsy
Juan Enrique Bender del Busto*
Neurology Department, International Center of Neurological Restoration, Cuba
*Corresponding Author: Juan Enrique Bender del Busto, Neurology Department, International Center of Neurological Restoration, Cuba.
Received: May 23, 2022; Published: May 26, 2022

Epilepsy is a disease that represents a public health problem, which needs comprehensive care [1,2]. It is considered to affect 1 - 2% of the population [1-6], with an estimated 50 to 69 million people suffering from this disease, the majority living in developing countries, where quality of life is worse [2].

This disease, in turn, can be a cause of death, a danger that is not taken into account and could be preventable [7] and, therefore, can reduce the life expectancy of patients [8].


  1. Organización Panamericana de la Salud. “Informe sobre la epilepsia en Latinoamérica”. Panamá: Panamá (2008).
  2. Bender del Busto JE. “La epilepsia, un problema de salud a escala mundial”. Revista Habanera de Ciencias Médicas (2018): 660-663.
  3. Wilmshurst JM., et al. “Epilepsy is ubiquitous, but more devastating in the poorer regions of the world. . . or is it?” Epilepsia (2014): 1322-1325.
  4. Linehan C and Berg A. “Epidemiology aspects of epilepsy”. In: E. Wyllie (Edition) Wyllie’s treatment of epilepsy. Principles and practice. Philadelphia, USA. Copyright © Wolters Kluwer (2015): 47-62.
  5. Bell GS., et al. “An unknown quantity-The worldwide prevalence of epilepsy”. Epilepsia (2014): 958-962.
  6. Beghi E and Hesdorffer D. “Prevalence of epilepsy-An unknown quantity”. Epilepsia (2014): 963-967.
  7. Tiana N., et al. “Cause-specific mortality among children and young adults with epilepsy: Results from the U.S. National Child Death Review Case Reporting System”. Epilepsy and Behavior (2015): 31-34.
  8. Zimmerman R and Sirven J. “An overview of surgery for chronic seizures”. Retraccion (2003): 109-117.
  9. Engel J., et al. “Practice parameter: Temporal lobe and localized neocortical resections for epilepsy”. Neurology (2003): 538-547.
  10. Bender JE y González J. “Evaluación clínica pre y postquirúrgica”. En: L.M. Morales (Edition). Epilepsias farmacorresistentes. Su tratamiento en Cuba. La Habana, Cuba. Editorial Ciencias Médicas (2017): 9-18.
  11. Bender del Busto and Morell y García. “Mortalidad en epilepsia en la provincia de Santi Spíritus, Cuba”. Revista Mexicana de Neurociencia (2001): 40-47.
  12. Bender del Busto JE., et al. “Integral Approach to the Management of the Patient with Epilepsy”. Neurological Disorders and Epilepsy Journal 1 (2021): 138.
  13. Bender del Busto., et al. Chihuahua, México: Universidad Autónoma de Ciudad Juárez, Primera edición --Ciudad Juárez, 201 páginas (2021).
  14. Gastaut H., et al. “A proposed international classification of epileptic seizures”. Epilepsia (1964): 297-306.
  15. Gastaut H. “Classification of the epilepsies. Proposal for an international classification”. Epilepsia (1969): S14-S21.
  16. Fisher RS., et al. “Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)”. Epilepsia (2005): 470-472.
  17. Engel J. “Report of the ILAE classification core group”. Epilepsia (2006): 1558-1568.
  18. Bender dB. “Manejo integral del paciente con epilepsia. Deutschland, Alemania”. Editorial Academica Española (2014).
  19. Robert S Fisher., et al. “A practical clinical definition of epilepsy”. Epilepsia (2014): 1-8.
  20. Bender dB. “Atención al paciente con epilepsia. León, Nicaragua”. Editorial Universitaria UNAN-León (2014).
  21. Kanner AM., et al. “Supplementary motor seizures mimicking pseudoseizures: some clinical differences”. Neurology (1990): 1404-1407.
  22. Rabe EF. “Recurrent paroxysmal nonepileptic disorders”. Current Problems in Pediatric (1974): 1-31.
  23. Metrick ME., et al. “Nonepileptic events in childhood”. Epilepsia (1991): 322-328.
  24. King DW., et al. “Pseudoseizures: diagnostic evaluation”. Neurology (1982): 18-23.
  25. So N and Andermann F. “A Comprehensive Textbook”. Philadelphia, USA. PA: Lippincott-Raven (1998).
  26. Prensky A. “Pediatric Epilepsy: Diagnosis and Therapy”. New York, USA. Demos Medical Publishing (2001).
  27. Terra V and Sakamoto A. “Tratamiento Farmacológico de las Epilepsias”. Bela Vista-Sao Paulo, Brazil. Leitura Médica Ltda (2014).
  28. Salinsky M., et al. “Psychogenic nonepileptic seizures in US veterans”. Neurology (2011): 945-950.
  29. Lesser RP. “Psychogenic seizures”. Neurology (1996): 1499-1507.
  30. Benbadis SR and Allen Hauser W. “An estimate of the prevalence of psychogenic non-epileptic seizures”. Seizure (2000): 280-281.
  31. Jerome E and Timothy P. “Epilepsy: A Comprehensive Textbook”. Philadelphia, USA. Copyright © Lippincott Williams and Wilkins (2008).
  32. Pestana Knight EM and Pellock JM. “Wyllie’s treatment of epilepsy principles and practice. Philadelphia, USA”. Copyright © Wolters Kluwer (2015).
  33. Engel JP. “Tratados médicos de Hipocrates sobre la enfermedad sagrada”. Barcelona, España: Gredos (1990).
  34. Maya Entenza CM. “Neurología clínica fundamental”. T. 1. La Habana: Editorial Ciencias Médicas (2019).
  35. Pack AM. “Epilepsy overview and revised classification of seizures and epilepsies”. Continuum (Minneap Minn) (Epilepsy) (2019): 306-321.
  36. Scheffer IE., et al. “Classification of the epilepsies: New concepts for discussion and Debate-Special report of the ILAE Classification Task Force of the Comission for Classification and Terminology”. Epilepsia Open (2016): 37-44.
  37. Scheffer IE., et al. “ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology”. Epilepsia (2017): 512-521.
  38. Fisher RS., et al. “Clasificación operacional de los tipos de crisis por la Liga Internacional contra la Epilepsia: Documento - Posición de la Comisión para Clasificación y Terminología de la ILAE”. Epilepsia (2017): 522-530.
  39. Blumenfeld H. “What is a seizure network? Long-range network consequences of focal seizures”. Advances in Experimental Medicine and Biology (2014): 63-70.
  40. Reséndiz-Aparicio JC., et al. “Clinical guideline: definition and classification of epilepsy”. Revista Mexicana de Neurociencia (2019): 63-68.
  41. Shorvon SD. “The causes of epilepsy: Changing concepts of etiology of epilepsy over the past 150 years”. Epilepsia (2011): 1033-1044.
  42. Gil-Nagel A and García I. “Etiopatogenia y fisiopatología de la epilepsia”. Medicine (2007): 4806-4813.
  43. Cendes F., et al. “Neuroimaging of epilepsy”. Cleveland, OH, USA. Handbook of Clinical Neurology (2016).
  44. Dieter S and Shorvon SD. “The End of Epilepsy? A history of the Modern Era of Epilepsy Research 1860-2010. Oxford, USA”. Oxford University Press (2016).
  45. McTague A., et al. “The genetic landscape of the epileptic encephalopathies of infancy and childhood”. The Lancet Neurology (2016): 304-316.
  46. Lafrance WC and Hamid HI. “Psychogenic nonepileptic seizures”. In: E. Wyllie (Edition). Wyllie’s treatment of epilepsy principles and practice. Philadelphia, USA. Copyright © Wolters Kluwer (2015): 876-885.
  47. Pestana Knight EM and Pellok JM. “Other nonepileptic paroxysmal disorders”. In: E. Wyllie (Edition). Wyllie’s treatment of epilepsy principles and practice. Philadelphia, USA. Copyright © Wolters Kluwer (2015): 886-906.
  48. Bender del Busto JE and Hernandez Toledo L. “Consideraciones del tratamiento del paciente con epilepsia. Artículo de revisión”. Revista Habanera de Ciencias Médicas 6 (2017): 912-926.
  49. Guía Clínica Auge. “Epilepsia adultos”. Santiago, Chile. Ministerio de Salud. Serie Guías Clínicas MINSAL (2014).
  50. Zhu HL., et al. “Medicinal compounds with antiepileptic/anticonvulsant activities”. Epilepsia (2014): 3-16.
  51. Putnam TJ and Merritt HH. “Experimental determination of the anticonvulsant properties of some phenyl derivatives”. Science (1937): 525-526.
  52. Pereira L. “Tratamiento Farmacológico de las Epilepsias”. Bela Vista-Sao Paulo, Brazil. Leitura Médica Ltda (2014).
  53. Varda GT., et al. “Initiation and discontinuation of antiepileptic drugs”. In: E. Wyllie (Edition). Wyllie’s treatment of epilepsy principles and practice. Philadelphia, USA. Copyright © Wolters Kluwer (2015): 946-967.
  54. Barker-Haliski ML and White HS. “Antiepileptic drug development and experimental models”. In: E. Wyllie (Edition). Wyllie’s treatment of epilepsy principles and practice. Philadelphia, USA. Copyright © Wolters Kluwer (2015): 909-917.
  55. Scott RC. “Network science for the identification of novel therapeutic targets in epilepsy”. Research (2016): 893.
  56. Ferraro TN. “Genetic influences on responses to drugs used to treat epilepsy”. In: E. Wyllie (Edition). Wyllie’s treatment of epilepsy principles and practice. Philadelphia, USA. Copyright © Wolters Kluwer (2015): 1003-1035.
  57. Fisher RS. “Therapeutic devices for epilepsy”. Annals of Neurology (2012): 157-168.
  58. Maydell BV., et al. “Efficacy of the ketogenic diet in focal versus generalized seizures”. Pediatric Neurology (2001): 208-212.
Citation: Juan Enrique Bender del Busto. “A Necessary Reflection on the Comprehensive Care of Patients with Epilepsy”. EC Neurology 14.6 (2022): 01-07.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 20, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.